Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioVenture

Founders Jacky Chen

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 116
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 101
Rounds per year 10.55
Lead investments 28
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Pharmaceutical
  • Medical Device
Summary

BioVenture appeared to be the VC, which was created in 2013. The main department of described VC is located in the Suzhou. The fund was located in Asia if to be more exact in China.

Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this BioVenture works on 24 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2018. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.

The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight inui Health, LAM Therapeutics, Innovita Biological Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Health Diagnostics, Therapeutics.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the BioVenture, startups are often financed by Yueyin Venture Capital, Proxima Ventures Ltd, Luc De Vos. The meaningful sponsors for the fund in investment in the same round are OrbiMed, CD Capital, iGlobe Partners. In the next rounds fund is usually obtained by YuanMing Capital, Sanofi, Qiming Venture Partners.

This organization was formed by Jacky Chen.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioVenture:
Typical Co-investors
BioVenture is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioVenture:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Youzhong New Material Technology

$15M29 Apr 2024 Zhoushan, Zhejiang, China

Secretech

Health Care
Medical
19 Jan 2024 Shenzhen, Guangdong, China

Changsha Morning Shine

Biopharma
Medical
Outsourcing
Pharmaceutical
$15M14 Dec 2023 Hunan, Hunan, China

Gachun Biotech

Biotechnology
Medical
Pharmaceutical
$15M23 Nov 2023 Chengdu, Sichuan, China

Essentia Biosciences

Biotechnology
Genetics
Pharmaceutical
24 Oct 2023 Haidian, Beijing, China

Jiamuyao Medical

Health Care
Medical
24 Jul 2023 Shanghai, Shanghai, China

Xiguang Bio

Biotechnology
Health Care
Medical
$15M19 Jul 2023 -

Panomic Biomedical Technology

Analytics
Bioinformatics
Biotechnology
Health Care
Life Science
Medical
$15M28 Jun 2023 Suzhou, Jiangsu, China

Chromai

Health Care
Health Diagnostics
Medical
$15M05 Jun 2023 Shunyi, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioVenture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 116
Average round size 15M
Rounds per year 10.55
Peak activity year 2021
Lead investments 28
Follow on index 0.11
Exits 3
Group Appearance index 0.70

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Youzhong New Material Technology

$15M29 Apr 2024 Zhoushan, Zhejiang, China

Secretech

Health Care
Medical
19 Jan 2024 Shenzhen, Guangdong, China

Changsha Morning Shine

Biopharma
Medical
Outsourcing
Pharmaceutical
$15M14 Dec 2023 Hunan, Hunan, China

Gachun Biotech

Biotechnology
Medical
Pharmaceutical
$15M23 Nov 2023 Chengdu, Sichuan, China

Essentia Biosciences

Biotechnology
Genetics
Pharmaceutical
24 Oct 2023 Haidian, Beijing, China

Jiamuyao Medical

Health Care
Medical
24 Jul 2023 Shanghai, Shanghai, China

Xiguang Bio

Biotechnology
Health Care
Medical
$15M19 Jul 2023 -

Panomic Biomedical Technology

Analytics
Bioinformatics
Biotechnology
Health Care
Life Science
Medical
$15M28 Jun 2023 Suzhou, Jiangsu, China

Chromai

Health Care
Health Diagnostics
Medical
$15M05 Jun 2023 Shunyi, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: